06.02.2019 17:40:34
|
NEURONES: 5% organic growth in 2018
PRESS INFORMATION
Heading: 2018 annual revenues
Nanterre, February 6, 2019 (after the closing of the stock exchange)
5% organic growth in 2018
(unaudited and in millions of euros) | 2017 published | 2017 restated IFRS 15 | 2018 | Growth as per iso-method | of which organic |
Revenues | 485 | 475.5 | 490.1 | + 3.1% | + 5% |
Achievements
In a continuingly buoyant environment driven by digital transformation (agile methods, devops, cloud computing, cybersecurity, mobility, IoT, big data and analytics, AI, etc.), revenues growth is high at + 5% on a constant method and consolidation basis.
The revenues goal was reached, despite a context of persistent recruitment tensions.
At 46 M€, the operating profit (*) was up and represented 9.4% of revenues (as against 9.3% in 2017).
Cash generation was high, with net cash of 174.5 M€ after the closing of the stock exchange (up 21.4 M€ over the previous financial year).
The group's payroll was 5,160 employees at year's end.
The comprehensive final annual financial statements will be published on Wednesday 13 March 2019 after the closing of the stock exchange.
(*) under audit and after 0.2% of free shares related cost.
Outlook
As usual, forecasts for the current year will be posted along with the Group's 1st quarter revenues.
About NEURONES
With 5,200 experts, the NEURONES group specializes in Consulting (Management, Organization and Digital) and IT Services. It assists its clients with their digital transformation projects and with the upgrading and outsourcing of their information systems.
Euronext Paris (compartment B - NRO) - Enternext Tech 40 - SRD medium values
Press Relations: Florence Gillier Communication Sabine GROSDIDIER Tel.: +33 (0)1 41 18 85 55 sabineg@fgcom.fr | NEURONES Matthieu VAUTIER Tel.: +33 (0)1 41 37 41 37 rp@neurones.net |
Investor Relations: NEURONES Paul-César BONNEL Tel.: +33 (0)1 41 37 41 37 investisseurs@neurones.net |
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NEURONES via Globenewswire
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu NeuronesAct.mehr Nachrichten
Keine Nachrichten verfügbar. |